Efficacy and safety of different interventions in castration resistant prostate cancer progressing after docetaxel-based chemotherapy: Bayesian network analysis of randomized controlled trials

Conclusions: Our results demonstrated that Abiraterone Acetate might be the optimal intervention for CRPC patients after docetaxel failure with acceptable tolerability. Future well-designed RCTs and systematic reviews are needed to validate these findings.

Source: Journal of Cancer - June 20, 2018 Category: Cancer & Oncology Authors: Yue Zhao, Hao Huang, Changhao Chen, Hao Liu, Hongwei Liu, Feng Su, Junming Bi, Thomas B. Lam, Jiaping Li, Tianxin Lin, Jian Huang Tags: Research Paper Source Type: research